北京中医药大学学报
北京中醫藥大學學報
북경중의약대학학보
Journal of Beijing University of Traditional Chinese Medicine
2015年
9期
645-648
,共4页
王芷乔%吕萌%周玉%夏仲元
王芷喬%呂萌%週玉%夏仲元
왕지교%려맹%주옥%하중원
甲状腺癌%术后%中医证候%临床调查
甲狀腺癌%術後%中醫證候%臨床調查
갑상선암%술후%중의증후%림상조사
cancerous goiter%postoperative%TCM syndromes%clinical survey
目的:对甲状腺癌术后患者的中医证候进行调查,明确证候分布及症状表现,为甲状腺癌的中医辨证论治提供依据。方法结合文献研究和中医理论,制定“甲状腺癌中医证候学调查表”,对183例甲状腺癌术后患者进行中医证候横断面调查。结果183例甲状腺癌术后患者中气阴两虚证63例(34.43%),肝郁气滞证48例(26.23%),痰瘀互结证45例(24.59%),脾肾阳虚证27例(14.75%)。不同年龄与不同病程的甲状腺癌患者,中医证候分型无统计学差异(P<0.05)。结论甲状腺癌术后患者中医证型的分布规律对于临床辨证具有一定指导意义。
目的:對甲狀腺癌術後患者的中醫證候進行調查,明確證候分佈及癥狀錶現,為甲狀腺癌的中醫辨證論治提供依據。方法結閤文獻研究和中醫理論,製定“甲狀腺癌中醫證候學調查錶”,對183例甲狀腺癌術後患者進行中醫證候橫斷麵調查。結果183例甲狀腺癌術後患者中氣陰兩虛證63例(34.43%),肝鬱氣滯證48例(26.23%),痰瘀互結證45例(24.59%),脾腎暘虛證27例(14.75%)。不同年齡與不同病程的甲狀腺癌患者,中醫證候分型無統計學差異(P<0.05)。結論甲狀腺癌術後患者中醫證型的分佈規律對于臨床辨證具有一定指導意義。
목적:대갑상선암술후환자적중의증후진행조사,명학증후분포급증상표현,위갑상선암적중의변증론치제공의거。방법결합문헌연구화중의이론,제정“갑상선암중의증후학조사표”,대183례갑상선암술후환자진행중의증후횡단면조사。결과183례갑상선암술후환자중기음량허증63례(34.43%),간욱기체증48례(26.23%),담어호결증45례(24.59%),비신양허증27례(14.75%)。불동년령여불동병정적갑상선암환자,중의증후분형무통계학차이(P<0.05)。결론갑상선암술후환자중의증형적분포규률대우림상변증구유일정지도의의。
Objective To reveal the rule of TCM syndromes of postoperative patients with cancerous goi-ter and to provide clinical evidence for TCM treatment on the patients.Methods Based on the literature search and TCM standard of syndromes, Questionnaire of TCM Syndromes of Patients with Cancerous Goi-ter was established.A cross-sectional study of TCM syndromes was performed on 183 postoperative pa-tients with cancerous goiter.Results Altogether four TCM syndromes existed in 183 patients.The ratio of syndrome of deficiency of both vital qi and yin was 34 .43%( n=63 ) , that of syndrome of stagnation of liver qi was 26.23%(n=48), that of syndrome of intermingled phlegm and blood stasis was 24.59%(n=45) and that of syndrome of yang deficiency of spleen and kidney was 14.75%(n=27).Further-more, distribution of TCM syndrome types showed no statistically differences(P<0.05) among ages and disease courses.Conclusion The rule of distribution of TCM syndromes in postoperative patients with cancerous goiter would guide the syndrome differentiation and treatment.